Cardiac Glycoside Plant Poisoning Clinical Presentation

  • Author: Raffi Kapitanyan, MD; Chief Editor: Asim Tarabar, MD   more...
 
Updated: May 10, 2011
 

History

As with all toxic exposures, history should focus on answering the following 6 key questions:

  • Who was exposed and are there other victims?
  • To what were they exposed?
  • When were they exposed?
  • Where were they exposed?
  • Why were they exposed (unintentional vs intentional)?
  • To how much were they exposed (eg, amount, concentration)?

Although acute and chronic plant cardiac glycoside toxicity are treated in similar manners, their noncardiac clinical manifestations differ. In acute toxicity, the following may be present:

  • GI symptoms, usually evolve within minutes to hours, are nonspecific, and include nausea, vomiting, and abdominal pain.
  • Neurological symptoms often are nonspecific and include weakness and altered mental status (eg, disorientation, confusion, lethargy).

In chronic toxicity, signs and symptoms are insidious, which make diagnose difficult at times. GI symptoms are nonspecific and include anorexia, nausea, vomiting, diarrhea, abdominal pain, and weight loss. Neurological symptoms include confusion, drowsiness, disorientation, delirium, headache, hallucinations, and seizures. Visual disturbances manifest as photophobia, blurry vision, scotomas, decreased visual acuity, and color vision aberrations (eg, chromatopsia, xanthopsia [ie, yellow halos around lights]).

Cardiac symptoms are similar in both acute and chronic toxicity and include palpitations, chest pressure or shortness of breath, lightheadedness, dizziness, and faintness.

Next

Physical

Focus is on cardiovascular, neurologic, and GI systems.

Vital signs

Bradycardia or tachycardia may be seen. In absence of concomitant ingestion, environmental exposure, thyroid disorder, or underlying infection, patient generally is normothermic.

Lungs

Examination findings typically are normal in the absence of preexisting disease, but rales have been reported.

Heart

Bradydysrhythmias or tachydysrhythmias can occur, typically with increased automaticity and depressed conduction. Pulses may be weak, thready, and irregular.

Abdomen

Abdomen is generally soft. Vomiting and diarrhea may be noted. Emesis may contain plant material.

Neurologic

Findings may include an altered level of consciousness, hypotonia, hyporeflexia, dysarthria, ataxia, horizontal nystagmus, and generalized seizures. The patient typically has a nonfocal neurologic examination with pupillary reflexes intact.

Skin

Skin may be pale, diaphoretic, and cool.

Previous
Next

Causes

Exposure to plants containing glycosides can occur through ingestion of sap, berries, leaves, blossoms, seeds, or ingestion of teas brewed from plant parts; plant extracts also have been intentionally injected.

Other implicated routes of exposures, perhaps more folkloric than well documented, include drinking lily-of-the-valley vase water, eating food prepared with or stirred by poisonous plant parts, and inhaling smoke from burning plants.

While there are many plant sources of cardiac glycosides, common ones include the following:

  • Purple foxglove (Digitalis purpurea)
  • Woolly foxglove (Digitalis lanata)
  • Ouabain (Strophanthus gratus)
  • Lily-of-the-valley (Convallaria majalis)
  • Common oleander (Nerium oleander)
  • Yellow oleander (Thevetia peruviana)
  • Squill or sea onion (Urginea maritima)
Previous
 
 
Contributor Information and Disclosures
Author

Raffi Kapitanyan, MD  Assistant Professor of Emergency Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School

Raffi Kapitanyan, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Mark Su, MD, FACEP, FACMT  Consulting Staff and Director of Fellowship in Medical Toxicology, Department of Emergency Medicine, North Shore University Hospital; Consulting Staff, North Shore University Hospital

Mark Su, MD, FACEP, FACMT is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Douglas R Landry, MD  Consulting Staff, Department of Emergency Medicine, Sentara Bayside Hospital

Douglas R Landry, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Specialty Editor Board

B Zane Horowitz, MD, FACMT  Professor, Department of Emergency Medicine, Oregon Health and Sciences University; Medical Director, Oregon Poison Center; Medical Director, Alaska Poison Control System

B Zane Horowitz, MD, FACMT is a member of the following medical societies: American Academy of Clinical Toxicology and American College of Medical Toxicology

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD  Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

Michael Hodgman, MD  Assistant Clinical Professor of Medicine, Department of Emergency Medicine, Bassett Healthcare

Michael Hodgman, MD is a member of the following medical societies: American College of Medical Toxicology, American College of Physicians, Medical Society of the State of New York, and Wilderness Medical Society

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD  Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure: Nothing to disclose.

References
  1. Bessen HA. Therapeutic and toxic effects of digitalis: William Withering, 1785. J Emerg Med. 1986;4(3):243-8. [Medline].

  2. Bronstein, AC, Spyker, DA, Cantilena Jr., LR, et al. 2006 annual report of the American Association of Poison Control Centers National Poison Data System. Clinical Toxicology. Dec 2007;45(8):815-917.

  3. Eddleston M, Ariaratnam CA, Sjostrom L, Jayalath S, Rajakanthan K, Rajapakse S. Acute yellow oleander (Thevetia peruviana) poisoning: cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside concentrations on presentation to hospital. Heart. Mar 2000;83(3):301-6. [Medline].

  4. Gowda RM, Cohen RA, Khan IA. Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications. Heart. Apr 2003;89(4):e14. [Medline].

  5. Hack JB, Woody JH, Lewis DE, et al. The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol Clin Toxicol. 2004;42(4):337-42. [Medline].

  6. Roberts DM, Buckley NA. Antidotes for acute cardenolide (cardiac glycoside) poisoning. Cochrane Database Syst Rev. Oct 18 2006;CD005490. [Medline].

  7. Bain RJ. Accidental digitalis poisoning due to drinking herbal tea. Br Med J (Clin Res Ed). Jun 1 1985;290(6482):1624. [Medline].

  8. Cheung K, Urech R, Taylor L. Plant cardiac glycosides and digoxin Fab antibody. J Paediatr Child Health. Oct 1991;27(5):312-3. [Medline].

  9. Dickstein ES, Kunkel FW. Foxglove tea poisoning. Am J Med. Jul 1980;69(1):167-9. [Medline].

  10. Eddleston M, Rajapakse S, Rajakanthan, Jayalath S, Sjostrom L, Santharaj W. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet. Mar 18 2000;355(9208):967-72. [Medline].

  11. el Bahri L, Djegham M, Makhlouf M. Urginea maritima L (Squill): a poisonous plant of North Africa. Vet Hum Toxicol. Apr 2000;42(2):108-10. [Medline].

  12. Furbee B, Wermuth M. Life-threatening plant poisoning. Crit Care Clin. Oct 1997;13(4):849-88. [Medline].

  13. Goldfrank, Flomenbaum, Lewin, et al. Cardiac glycosides. In: Goldfrank's Toxicologic Emergencies. 7th ed. 2002:724-734.

  14. Rich SA, Libera JM, Locke RJ. Treatment of foxglove extract poisoning with digoxin-specific Fab fragments. Ann Emerg Med. Dec 1993;22(12):1904-7. [Medline].

  15. Plants - cardiac glycosides. In: Rumack BH, ed. Poisondex. 1997:94.

  16. Slifman NR, Obermeyer WR, Aloi BK, Musser SM, Correll WA Jr, Cichowicz SM. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med. Sep 17 1998;339(12):806-11. [Medline].

  17. Van Deusen SK, Birkhahn RH, Gaeta TJ. Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity. J Toxicol Clin Toxicol. 2003;41(4):373-6. [Medline].

Previous
Next
 
The plant shown is foxglove (Digitalis purpura), which contains cardiac glycosides, not tropane alkaloids. © 2000 Richard Wagner
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.